The funding brings Ganymed Robotics’ total to 35 million Euros, or approximately $38.2 million, according to a news release. The combined funds will help complete the company’s development of a total knee replacement robot, accelerate regulatory market activities and bolster the innovation product pipeline.
Ganymed Robotic in July raised 21 million Euros, or approximately $21.3 million. The company was founded in 2018.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.